Search

Golub, T. R., G. F. Barker, M. Lovett, and D. G. Gilliland. 1994. “Fusion of PDGF Receptor Beta to a Novel Ets-Like Gene, Tel, in Chronic Myelomonocytic Leukemia With T(5;12) Chromosomal Translocation”. Cell 77: 307-16.

Golub, T. R., G. F. Barker, K. Stegmaier, and D. G. Gilliland. 1997. “The TEL Gene Contributes to the Pathogenesis of Myeloid and Lymphoid Leukemias by Diverse Molecular Genetic Mechanisms”. Curr Top Microbiol Immunol 220: 67-79.

Hieronymus, H., J. Lamb, K. N. Ross, X. P. Peng, C. Clement, A. Rodina, M. Nieto, et al. 2006. “Gene Expression Signature-Based Chemical Genomic Prediction Identifies a Novel Class of HSP90 Pathway Modulators”. Cancer Cell 10: 321-30.

Ikeda, S., S. W. Kong, J. Lu, E. Bisping, H. Zhang, P. D. Allen, T. R. Golub, B. Pieske, and W. T. Pu. 2007. “Altered MicroRNA Expression in Human Heart Disease”. Physiol Genomics 31: 367-73.

Wasswa, George. 2014. “A Re-Examination of Race in the U.S.”. Political Science 1 (15).

Kamburov, A., M. S. Lawrence, P. Polak, I. Leshchiner, K. Lage, T. R. Golub, E. S. Lander, and G. Getz. 2015. “Comprehensive Assessment of Cancer Missense Mutation Clustering in Protein Structures”. Proc Natl Acad Sci U S A 112: E5486-95.

Kumar, M. S., R. E. Pester, C. Y. Chen, K. Lane, C. Chin, J. Lu, D. G. Kirsch, T. R. Golub, and T. Jacks. 2009. “Dicer1 Functions As a Haploinsufficient Tumor Suppressor”. Genes Dev 23: 2700-4.

Lamb, J., S. Ramaswamy, H. L. Ford, B. Contreras, R. V. Martinez, F. S. Kittrell, C. A. Zahnow, N. Patterson, T. R. Golub, and M. E. Ewen. 2003. “A Mechanism of Cyclin D1 Action Encoded in the Patterns of Gene Expression in Human Cancer”. Cell 114: 323-34.

Lechman, E. R., B. Gentner, S. W. Ng, E. M. Schoof, P. Galen, J. A. Kennedy, S. Nucera, et al. 2016. “MiR-126 Regulates Distinct Self-Renewal Outcomes in Normal and Malignant Hematopoietic Stem Cells”. Cancer Cell 29: 214-28.

Levine, R. L., M. Wadleigh, J. Cools, B. L. Ebert, G. Wernig, B. J. Huntly, T. J. Boggon, et al. 2005. “Activating Mutation in the Tyrosine Kinase JAK2 in Polycythemia Vera, Essential Thrombocythemia, and Myeloid Metaplasia With Myelofibrosis”. Cancer Cell 7: 387-97.